Neumora Therapeutics Inc.... (NMRA)
NASDAQ: NMRA
· Real-Time Price · USD
1.62
0.04 (2.53%)
At close: Aug 15, 2025, 3:59 PM
1.66
2.47%
After-hours: Aug 15, 2025, 07:51 PM EDT
Neumora Therapeutics Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -252.09M | -258.06M | -243.79M | -293.7M | -274.18M | -254.02M | -235.93M | -155.34M | -131.66M | -123.49M | -130.9M | -129.73M | -278.41M | -265.05M | -237.31M | -230.34M | -52.31M | -35.3M |
Depreciation & Amortization | 489K | 630K | 631K | 640K | 657K | 668K | 668K | 649K | 622K | 605K | 594K | 578K | 582K | 553K | 538K | 470K | 320K | 195K |
Stock-Based Compensation | 36.34M | 41.94M | 39.99M | 36.14M | 32.64M | 22.42M | 17.24M | 13.98M | 9.63M | 8.84M | 8.3M | 6.72M | 5.81M | 5.12M | 4.27M | 3.88M | 2.69M | 1.63M |
Other Working Capital | 3.69M | -4.93M | -4.23M | -16.97M | -18.89M | -12.2M | -8.32M | 814K | 2.27M | 4.66M | -5.7M | -7.25M | -4.71M | -3.3M | -202K | 2.69M | 205K | -1.67M |
Other Non-Cash Items | 16.44M | 21.94M | 22.73M | 87.81M | 65.15M | 67.36M | 67.38M | 3.32M | 3.49M | 2.94M | 15.35M | 15.3M | 171.45M | 171.22M | 158.04M | 162.16M | 4.98M | 4.91M |
Deferred Income Tax | n/a | n/a | n/a | -673K | -1.71M | -1.71M | -1.71M | -1.82M | -1.03M | -1.18M | -1.28M | -557K | 9K | -44K | -53K | 220K | -96K | 102K |
Change in Working Capital | 3.56M | -5.47M | -1.36M | -13.11M | -19.75M | -5.62M | -8.9M | -964K | 784K | -2.58M | -6.95M | -6.25M | -4.55M | -4.09M | -961K | 1.25M | -1M | -3.19M |
Operating Cash Flow | -195.68M | -199.43M | -182.94M | -184.04M | -198.33M | -173.19M | -163.28M | -142.2M | -120.19M | -115.75M | -114.9M | -113.88M | -105.38M | -92.36M | -75.42M | -62.58M | -45.32M | -31.76M |
Capital Expenditures | 775K | 775K | n/a | -44K | -856K | -856K | -117K | -96K | -189K | -371K | -511K | -676K | -763K | -720K | -817K | -1.93M | -1.71M | -1.57M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 300K | 300K | 300K | 300K |
Purchase of Investments | -191.94M | -172.09M | -312.22M | -225.4M | -238.27M | -253.39M | -109.07M | -137.09M | -136.72M | -195.42M | -226.37M | -178.27M | -165.79M | -72.43M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 322.41M | 294.41M | 242.44M | 272.72M | 152.46M | 170.41M | 178.17M | 179.87M | 172.46M | 116.2M | 71.87M | 31.78M | 2.48M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 1.49M | 514K | -1.55M | -6.14M | -5.37M | -5.37M | -4.59M | n/a | n/a | 2.48M | -10.52M | -10.52M | -10.85M | -13.3M | n/a | 990K | 1.32M | 1.29M |
Investing Cash Flow | 132.75M | 123.6M | -70.56M | 41.92M | -91.25M | -88.43M | 64.39M | 42.68M | 35.56M | -79.59M | -168.01M | -160.17M | -177.41M | -86.45M | -817K | -939K | -392K | -283K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -491K | -491K | -491K | -491K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 21.87M | 6.06M | 7.91M | 5.55M | 236.04M | 233.68M | 231.94M | 234.28M | 89.43M | 91.22M | 90.77M | 88.61M | 293.42M | 291.98M | 292.61M | 292.9M | 920K | 280K |
Financial Cash Flow | 35.56M | 19.76M | 21.6M | 5.55M | 236.04M | 233.68M | 231.94M | 259.25M | 114.4M | 116.19M | 115.74M | 88.55M | 293.36M | 291.92M | 293.51M | 305.67M | 13.68M | 13.04M |
Net Cash Flow | -26.16M | -54.85M | -230.68M | -135.36M | -53.54M | -27.94M | 133.04M | 159.73M | 29.77M | -79.15M | -167.17M | -185.5M | 10.57M | 113.1M | 217.27M | 242.15M | -32.03M | -19M |
Free Cash Flow | -194.9M | -198.65M | -182.94M | -184.08M | -199.18M | -174.05M | -163.4M | -142.3M | -120.38M | -116.12M | -115.41M | -114.56M | -106.14M | -93.08M | -76.24M | -64.51M | -47.03M | -33.33M |